Caris Life Sciences (CAI) Prepaid Assets (2024 - 2026)

Caris Life Sciences' (CAI) quarterly Prepaid Assets came in at $23.9 million in Q1 2026, up 915.37% quarter-over-quarter from $2.4 million in Q4 2025.

Caris Life Sciences (CAI) Prepaid Assets (2024 - 2026) Analysis & Trends

Caris Life Sciences' Prepaid Assets history runs 3 years deep, the most recent figure standing at $23.9 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets changed N/A year-over-year to $23.9 million in Q1 2026; TTM through Mar 2026 was $23.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.4 million, down 88.38% from the prior year.
  • Prepaid Assets rose to $23.9 million in Q1 2026 per CAI's latest filing, from $2.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $23.9 million in Q1 2026 and bottomed at $2.4 million in Q4 2025.
  • The 3-year median for Prepaid Assets is $2.6 million (2025), against an average of $10.3 million.
  • Biggest YoY gain for Prepaid Assets was 88.38% in 2025; the steepest drop was 88.38% in 2025.
  • Year by year, Prepaid Assets stood at $20.3 million in 2024, then sank by 88.38% to $2.4 million in 2025, then soared by 915.37% to $23.9 million in 2026.
  • Per Business Quant, the three latest CAI Prepaid Assets figures stand at $23.9 million (Q1 2026), $2.4 million (Q4 2025), and $2.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Caris Life Sciences 4.42 Bn 3.60 Bn 214.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.91 Mn
Dec 31, 2025 2.36 Mn
Sep 30, 2025 2.58 Mn
Jun 30, 2025 2.55 Mn
Dec 31, 2024 20.27 Mn